These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26646588)

  • 1. RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action.
    Masliah-Planchon J; Garinet S; Pasmant E
    Oncotarget; 2016 Jun; 7(25):38892-38907. PubMed ID: 26646588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer.
    Soleimani A; Rahmani F; Saeedi N; Ghaffarian R; Khazaei M; Ferns GA; Avan A; Hassanian SM
    J Cell Biochem; 2019 Dec; 120(12):19245-19253. PubMed ID: 31512778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.
    Whelan JT; Hollis SE; Cha DS; Asch AS; Lee MH
    J Cell Physiol; 2012 Mar; 227(3):1235-41. PubMed ID: 21688267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression.
    Asl ER; Amini M; Najafi S; Mansoori B; Mokhtarzadeh A; Mohammadi A; Lotfinejad P; Bagheri M; Shirjang S; Lotfi Z; Rasmi Y; Baradaran B
    Life Sci; 2021 Aug; 278():119499. PubMed ID: 33865878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.
    Kasinski AL; Slack FJ
    Curr Opin Mol Ther; 2010 Apr; 12(2):147-57. PubMed ID: 20373258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.
    Delire B; Stärkel P
    Eur J Clin Invest; 2015 Jun; 45(6):609-23. PubMed ID: 25832714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
    Imperial R; Toor OM; Hussain A; Subramanian J; Masood A
    Semin Cancer Biol; 2019 Feb; 54():14-28. PubMed ID: 29175106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS-mediated oncogenic signaling pathways in human malignancies.
    Khan AQ; Kuttikrishnan S; Siveen KS; Prabhu KS; Shanmugakonar M; Al-Naemi HA; Haris M; Dermime S; Uddin S
    Semin Cancer Biol; 2019 Feb; 54():1-13. PubMed ID: 29524560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer.
    Wang P; Zhu CF; Ma MZ; Chen G; Song M; Zeng ZL; Lu WH; Yang J; Wen S; Chiao PJ; Hu Y; Huang P
    Oncotarget; 2015 Aug; 6(25):21148-58. PubMed ID: 26020803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.
    Poenitzsch Strong AM; Setaluri V; Spiegelman VS
    Arch Biochem Biophys; 2014 Dec; 563():118-24. PubMed ID: 25043973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
    Ho JY; Hsu RJ; Liu JM; Chen SC; Liao GS; Gao HW; Yu CP
    Oncotarget; 2017 Apr; 8(14):22443-22459. PubMed ID: 27705918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
    Lv J; Wang J; Chang S; Liu M; Pang X
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):17-26. PubMed ID: 26487443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 and let-7 in the Ras and NF-κB pathways.
    Choudhury SN; Li Y
    Microrna; 2012; 1(1):65-9. PubMed ID: 25048092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
    Eleveld TF; Schild L; Koster J; Zwijnenburg DA; Alles LK; Ebus ME; Volckmann R; Tijtgat GA; van Sluis P; Versteeg R; Molenaar JJ
    Cancer Res; 2018 Nov; 78(21):6297-6307. PubMed ID: 30115695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the RAS-dependent chemoresistance: The Warburg connection.
    Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
    Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
    Kumamoto H; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
    Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
    Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.